Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG

XETRA:EFF

Deutsche Effecten & Wechsel Beteiligungs AG invests in companies, which focus on the areas of photonics and sensor systems, as well as biotechnology and information technology. The company is headquartered in Jena, Thueringen and currently employs 2 full-time employees. The company went IPO on 2010-04-29. The company concentrates on medium capitalized technology companies and supports them by equity capital, consults in corporate development and its sector network. The firm focuses its investments on companies operating primarily in the area of photonics and sensor systems. As of December 2011, the Company's portfolio consisted of Nanotron Technologies Ltd (engaged in wireless sensor networks, among others), IG Asset, Inc (engaged in the functional genome analysis), NOXXON Pharma AG (engaged in the development of pharmaceuticals on the basis of Spiegelmer technology)l, and iTAC Software (engaged in collaborative production management system for the discrete manufacturing industry). In June 2014, the Company acquired MueTec GmbH.